Wall Street couldn't move fast enough to reprice CNC after its April 28 earnings beat. The stock has rallied 56% in one month. And the lending market is now signalling that the short thesis has largely been abandoned.
The earnings reaction was stark. Centene posted a 24% single-day gain on April 28. That triggered a wave of analyst revisions the same morning.
B of A Securities made the boldest move. Kevin Fischbeck flipped from Underperform to Buy, lifting his target from $34 to $60 — a 76% increase. Cantor Fitzgerald's Sarah James also upgraded, moving from Neutral to Overweight with a $60 target.
Barclays, Oppenheimer, Truist Securities, UBS, Wells Fargo, and TD Cowen all raised targets the same week. The consensus mean now sits at $54.94. CNC closed at $58.27 on May 15 — already above that average.
The EPS momentum tells the same story. Centene's 30-day EPS momentum ranks at the 92nd percentile. Its 90-day reading sits at the 87th percentile. Analyst recommendation divergence ranks at the 97th percentile — one of the widest positive gaps in the market right now.
The short side has been unwinding. SI % of free float now stands at 2.51% — modest in absolute terms, but the direction is notable. Estimated short shares have fallen from roughly 16 million on May 12 to 12.3 million by May 14.
The borrow market reflects that retreat clearly. Cost to borrow has collapsed to 0.11% — down 63% in one week and 71% over the past month. Availability has surged alongside it. The ORTEX short score has drifted lower too, from 33.8 on May 12 to 31.3 on May 14, consistent with a market where bearish conviction is fading.
One signal runs against the grain. The put/call ratio hit 0.40 on May 15 — the highest in 20 days and a z-score of 2.06 relative to the 20-day mean of 0.34.
Options players are buying more protection relative to calls than they have in three weeks. After a 56% one-month run, that's not unusual. But it does suggest the options market is hedging against a pullback even as analysts remain broadly constructive.
Harris Associates added 5 million shares in the most recent reported quarter. Columbia Management added 3 million. Both are meaningful additions relative to existing positions. Next earnings land July 28 — the question is whether fundamentals can validate a stock now trading above the analyst consensus target.
Data summary
See the live data behind this article on ORTEX.
Open CNC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
